Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desmond Curran

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Human Vaccines & Immunotherapeutics|June 4, 2019
Evaluation of two frailty indices, with practical application in a vaccine clinical trialDesmond Curran, Melissa K Andrew, Myron J Levin, et al.
The Journal of Infection|February 12, 2018
Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective studyRuprecht Schmidt-Ott, Ulf Schutter, Jörg Simon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 13, 2020
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older AdultsKenneth E Schmader, Myron J Levin, Michael Chen, et al.
Journal of Managed Care & Specialty Pharmacy|October 12, 2020
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact modelBrandon J Patterson, William L Herring, Desiree Van Oorschot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prognostic factors for survival in adult patients with cerebral low-grade gliomaFrancesco Pignatti, Martin van den Bent, Desmond Curran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2026
Health-related quality of life in European older adults with respiratory syncytial virus over three respiratory syncytial virus seasonsManel Terns Riera, Rosa Prato, Alberto Pérez-Rubio, et al.
Vaccine|April 16, 2019
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysisAshleigh McGirr, Robyn Widenmaier, Desmond Curran, et al.
Drugs - Real World Outcomes|October 9, 2017
Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, JapanHiroyuki Nakamura, Akiko Mizukami, Koichi Adachi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximabDesmond Curran, Jordi Giralt, Paul M Harari, et al.
Journal of the American Geriatrics Society|November 16, 2020
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail IndividualsDesmond Curran, Joon H Kim, Sean Matthews, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Human Vaccines & Immunotherapeutics|June 4, 2019
Evaluation of two frailty indices, with practical application in a vaccine clinical trialDesmond Curran, Melissa K Andrew, Myron J Levin, et al.
The Journal of Infection|February 12, 2018
Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective studyRuprecht Schmidt-Ott, Ulf Schutter, Jörg Simon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 13, 2020
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older AdultsKenneth E Schmader, Myron J Levin, Michael Chen, et al.
Journal of Managed Care & Specialty Pharmacy|October 12, 2020
Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact modelBrandon J Patterson, William L Herring, Desiree Van Oorschot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prognostic factors for survival in adult patients with cerebral low-grade gliomaFrancesco Pignatti, Martin van den Bent, Desmond Curran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2026
Health-related quality of life in European older adults with respiratory syncytial virus over three respiratory syncytial virus seasonsManel Terns Riera, Rosa Prato, Alberto Pérez-Rubio, et al.
Vaccine|April 16, 2019
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysisAshleigh McGirr, Robyn Widenmaier, Desmond Curran, et al.
Drugs - Real World Outcomes|October 9, 2017
Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, JapanHiroyuki Nakamura, Akiko Mizukami, Koichi Adachi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximabDesmond Curran, Jordi Giralt, Paul M Harari, et al.
Journal of the American Geriatrics Society|November 16, 2020
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail IndividualsDesmond Curran, Joon H Kim, Sean Matthews, et al.
Pageof 9